Kanti Madhani.

Kanti Madhani is the Managing Director and founder of Laksh Finechem Private Limited — a WHO-GMP, FDA and ISO-certified Indian manufacturer of Active Pharmaceutical Ingredients (APIs), iodine derivatives, chiral resolving agents, iodophors, lithium derivatives and specialty chemicals. A first-generation, self-made entrepreneur based in Anand, Gujarat, he has built the company from a multi-purpose GMP plant at Vithal Udyognagar into a regulated supplier of pharmaceutical ingredients to customers across India and around the world.

The Founder — First-Generation, Self-Made

Kanti's entrepreneurial story is self-made. A first-generation businessman with no inherited enterprise behind him, he chose chemistry, chose Anand, and chose the regulated-pharma path. Laksh Finechem, founded in 2009, was built on a single conviction: that India can be a globally trusted source for regulated pharmaceutical ingredients when the operating discipline — quality, compliance, repeatability — is non-negotiable.

The category was unforgiving. Regulated APIs are sold on documentation as much as on chemistry — DMFs, COAs, batch records, audit trails, change-control logs. Laksh chose to lead with regulatory discipline. The plant was built GMP-first, the QC laboratory was scaled ahead of production demand, and the customer base courted was one that would audit hard and stay long.

The Operator

Day-to-day, Kanti runs Laksh Finechem as a hands-on Managing Director. The remit covers operations, R&D, quality control, regulatory affairs, customer chemistry, environmental compliance and the workforce of scientists and operators that keep the plant audit-ready. He works close to the bench — close to the QC laboratory, close to the production floor, close to the customers whose audit cycles drive everything.

The operating discipline shows up in how the business is structured: quality before quantity, compliance by design, real customer trust as the moat. Regulated pharma is an unforgiving category; the only durable differentiator is execution. That has been the starting philosophy and remains the operating one.

The Exporter

As an exporter, Kanti has steadily expanded Laksh Finechem's customer base beyond India — supplying regulated pharmaceutical and chemical customers globally on the strength of documented chemistry, audit-cleared facilities and reliable delivery cycles. The Star Manufacturer designation for the tartrate family is one recognition of that path; the more important one is the audit history that customers carry away in their files.

The export approach mirrors the operating culture — earn the customer, hold the quality, never undercut the chemistry. Indian fine chemicals compete globally on documented quality and reliability, not on lowest price; Kanti has built the company on that distinction since day one.

The Mentor · For First-Generation Founders

Kanti engages actively with younger founders in regulated pharma, fine chemicals, contract manufacturing and the broader ecosystem of Indian SMEs that supply the global pharmaceutical industry. As a first-generation founder who built Laksh from the ground up in an audit-heavy category, he is candid about what the work actually takes.

The conversations are direct. Founders reach out for a view on plant design for a multi-product API line, how to staff a QC laboratory for the first regulated audit, how to think about DMF filings in a new geography, how to win the first export customer without burning capital, how to navigate Pollution Control Board approvals in Gujarat, or how to structure a family-run chemical company for the next generation. He engages personally — the door stays open.

The Product Portfolio

Laksh Finechem's product portfolio spans:

• Active Pharmaceutical Ingredients — Gadodiamide, Gadobutrol, Caldiamide Sodium, Nimodipine, Felodipine and related APIs manufactured in a multi-purpose GMP facility.
• Iodine Derivatives — 1-Iodo Octane, 2-Iodo Propane, N Propyl Iodide, Pure Iodine Granules, Potassium Iodide Powder, P Iodoaniline Powder, Sodium Metaperiodate.
• Chiral Resolving Agents — Diethyl L Tartrate, Diisopropyl L Tartrate, Di Butyl L Tartrate, Dimethyl L Tartrate. Star Manufacturer designation for this family.
• Iodophor Liquids — 1.6%, 2%, 10% and 20% formulations for disinfection and laboratory use.
• Lithium Derivatives — Lithium Iodide, Lithium Carbonate USP, Lithium Acetate.
• Specialty Chemicals — N-Bromosuccinimide, Ethyl Glyoxylate, Methyl Glyoxylate, 2-Chloro-5-Iodo Benzoic Acid, Isopropyl 3-Aminocrotonate, 2-Methoxyethyl Acetoacetate.

Vision

A reliable, innovative, customer-oriented chemical company in the global arena.

The goal is plain — be one of the most admired Indian chemical manufacturers globally, while protecting the basics that the regulated-pharma industry was built on: product purity, environmental responsibility, worker safety, and customer chemistry that holds up over decades.

Every batch is a small step in that direction. Every customer is one more pharmaceutical company that trusts Indian manufacturing because it has watched ours hold up across audit cycles. Compound that across years, and an Indian fine-chemicals company can quietly become the reliable supplier the world's pharma industry needs more of.

Operating Principles

The way Kanti runs Laksh Finechem is anchored in six principles — the standards he won't compromise on, even as the business scales:

1. Quality before quantity — Components, chemistry, documentation and audit posture — non-negotiables. A pharmaceutical ingredient outlives its purchase order by years; the standard has to match the patient who eventually consumes it.
2. Compliance by design — WHO-GMP, FDA, ISO 9001, 14001 and 45001 are operating frameworks, not certificates on a wall. Compliance is built into how the plant runs daily — not retro-fitted before an audit.
3. Stay on the bench — Decisions made close to the QC laboratory, the production floor and the customer's audit team. Not from a glass tower.
4. The long horizon — Build a business that compounds for decades, not a single export tender. Time horizons measured in customer audit cycles, not quarters.
5. Cash before credit — Capacity expansions funded from internal accruals. Receivables managed tighter than payables. The plant grows from what it earns — and never on what it borrows beyond its means.
6. Open door for builders — Time given freely to younger founders building in regulated pharma, fine chemicals and disciplined family enterprises. The ecosystem rises together — and Indian chemistry is stronger when its first-generation operators back the next ones.

Reach the office

For media, partnership, mentorship and CSR enquiries, write to info@lakshfinechem.com or call +91 79427 06732. For product, sample and supply enquiries, route through Laksh Finechem directly.